SATT Occitanie Méditerranée

SATT Occitanie Méditerranée, operating under the brand AXLR, is a French technology transfer office (TTO) that facilitates the commercialization of academic research from the Occitanie region. As a private company with public shareholders, it invests in the maturation of early-stage technologies originating from public laboratories, funding proof-of-concept studies, prototyping, and intellectual property protection. The company's primary objective is to de-risk innovations to make them attractive for licensing to existing industrial partners or for the creation of spin-off startups. AXLR maintains a strong focus on life sciences, biotechnology, and healthcare, leveraging the dense scientific ecosystem of Montpellier and surrounding areas. Its portfolio includes a wide array of modalities, including small molecules, biologics, and medical devices, targeting diverse therapeutic areas such as oncology and infectious diseases. By bridging the gap between fundamental research and market application, AXLR plays a critical role in the regional and national innovation economy.